Q2FY22 Quarterly Result Announced for Krishna Institute of Medical Sciences Ltd.
Highlights: Q2 FY 22: Revenue was Rs. 4171 mn EBITDA was at 1342 mn PAT was at Rs. 843 mn H1 FY22 revenue and EBITDA growth are partly on account of the low base during the last financial year commenting on the performance, Dr. B. Bhaskara Rao, Managing Director said, "Q2 has been a busy quarter on multiple fronts. With COVID cases dropping significantly, we have now almost reached pre-COVID levels on most parameters. our OP and IP volumes across hospitals are robust. our transplantation programme led by Heart and Lung continues to be the leader nationally. In fact, we have now done the highest number of COVID Double lung transplants outside of the US. With the vaccination drive in full swing, we are hopeful that the coming quarters will see growth as during the pre-COVID Period" Result PDF11-11-2021